Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

• Main Authors: Alice Pisana (Author), Björn Wettermark (Author), Amanj Kurdi (Author), Biljana Tubic (Author), Caridad Pontes (Author), Corinne Zara (Author), Eric Van Ganse (Author), Guenka Petrova (Author), Ileana Mardare (Author), Jurij Fürst (Author), Marta Roig-Izquierdo (Author), Oyvind Melien (Author), Patricia Vella Bonanno (Author), Rita Banzi (Author), Vanda Marković-Peković (Author), Zornitsa Mitkova (Author), Brian Godman (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluation generates uncertainty over their cost-effective...